Emergent is hiring several positions at their Canton, MA site to support a growing portfolio of programs.

In June 2020, Emergent announced a $75M investment into its Canton, Massachusetts drug substance facility, increasing its campus footprint and expanding its manufacturing capabilities into viral vector-based gene therapy.